Prevalence of hospital-acquired infections in burn patients: A six-year experience from northern Iran
DOI:
https://doi.org/10.61882/jcbior.6.3.320Keywords:
Burn injury, Hospital-acquired infections, Bacterial pathogen, Pneumonia, MortalityAbstract
Burn injuries represent a major public health problem, particularly in low- and middle-income countries, where hospital-acquired infections (HAIs) are one of the leading cause of morbidity and mortality. Burn patients are especially vulnerable due to loss of skin barrier, immune suppression, prolonged hospitalization, and invasive procedures. Therefore, this study aimed to determine the six years prevalence of HAIs in burn patients admitted to a subspecialty center for burn accidents. A retrospective cross-sectional study was conducted at Velayat Hospital, Rasht, northern Iran, including all burn patients admitted between March 2018 and March 2023 with hospital stays longer than 48 hours. Demographic, clinical, microbiological, and outcome data were extracted from hospital records. A total of 1,098 HAIs were documented, corresponding to a prevalence of 3.7%. The mean age of infected patients was 39.4 ± 20.7 years, and 74.1% were male. Skin and soft tissue infections were most frequent (89%), followed by ventilator-associated pneumonia (VAP) (5%), bloodstream infections (4.1%), and urinary tract infections (1.5%). Pseudomonas spp. (33.1%) and Klebsiella spp. (14.1%) were the leading pathogens. Mortality occurred in 29% of infected patients, with the highest rate among VAP cases (80%). Higher TBSA burns (>30%) and older age were significantly associated with mortality. HAIs remain a serious complication among burn patients, with Pseudomonas spp. as the predominant pathogen and VAP as the leading risk factor of death. Targeted infection-control strategies, improved microbiological diagnostics, and focused interventions for high-TBSA patients are critical to improving outcomes in burn centers.
References
1. Peck MD. Epidemiology of burns throughout the world. Part I: Distribution and risk factors. Burns. 2011;37(7):1087-100.
DOI: 10.1016/j.burns.2011.06.005 PMID: 21802856
2. Opriessnig E, Luze H, Smolle C, Draschl A, Zrim R, Giretzlehner M, et al. Epidemiology of burn injury and the ideal dressing in global burn care - Regional differences explored. Burns. 2023;49(1):1-14.
DOI: 10.1016/j.burns.2022.06.018 PMID: 35843806
3. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006;19(2):403-34.
DOI: 10.1128/CMR.19.2.403-434.2006 PMID: 16614255
4. Brusselaers N, Monstrey S, Snoeij T, Vandijck D, Lizy C, Hoste E, et al. Morbidity and mortality of bloodstream infections in patients with severe burn injury. Am J Crit Care. 2010;19(6):e81-7. DOI: 10.4037/ajcc2010341 PMID: 21041189
5. Mozafari N, Abbasi Montazeri E, Moogahi S, Alavi SMA. Healthcare-Associated Infections' Characteristics Among Burn Patients and Risk Factors of Mortality: A Study Based on Data From a Tertiary Center in Iran: Nosocomial Infections Among Burn Patients. Can J Infect Dis Med Microbiol. 2024;2024:8707245.
DOI: 10.1155/2024/8707245 PMID: 39502520
6. Brusselaers N, Logie D, Vogelaers D, Monstrey S, Blot S. Burns, inhalation injury and ventilator-associated pneumonia: value of routine surveillance cultures. Burns. 2012;38(3):364-70.
DOI: 10.1016/j.burns.2011.09.005 PMID: 22040929
7. Ghashghaee A, Behzadifar M, Azari S, Farhadi Z, Luigi Bragazzi N, Behzadifar M, et al. Prevalence of nosocomial infections in Iran: A systematic review and meta-analysis. Med J Islam Repub Iran. 2018;32:48. DOI: 10.14196/mjiri.32.48 PMID: 30159299
8. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128-40. DOI: 10.1016/0196-6553(88)90053-3 PMID: 2841893
9. Rezai MS, Shahmohammadi S. Nosocomial Infections in Iranian Pediatric Patients With Burn Injuries: A Review. J Pediatr Rev. 2015;3(2):1-11. URL: http://jpr.mazums.ac.ir/article-1-102-en.html
10. Afkhamzadeh A, Majidi F, Ahmadi C. Risk factors for nosocomial infections among burn patients hospitalized in Tohid hospital, Sanandaj, Kurdistan Iran. Medical Journal of Mashhad university of Medical Sciences. 2016;59(4):225-232.
DOI: 10.22038/mjms.2016.8482
11. Davoudi AR, Najafi N, Hoseini Shirazi M, Ahangarkani F. Frequency of bacterial agents isolated from patients with nosocomial infection in teaching hospitals of Mazandaran University of Medical Sciences in 2012. Caspian J Intern Med. 2014;5(4):227-31. PMID: 25489435
12. Rogers AD, Argent AC, Rode H. Review article: ventilator-associated pneumonia in major burns. Ann Burns Fire Disasters. 2012;25(3):135-9. PMID: 23467023
13. Huang YZ, Lu GZ, Zhao HS, Liu LJ, Jin J, Wu YF, et al. Clinical features and mortality-related factors of extensive burns among young adults: the Kunshan disaster experience. Ann Transl Med. 2020;8(17):1053. DOI: 10.21037/atm-20-288 PMID: 33145272
14. Güldoğan CE, Kendirci M, Gündoğdu E, Yastı AÇ. Analysis of factors associated with mortality in major burn patients. Turk J Surg. 2018;35(3):155-164. DOI: 10.5152/turkjsurg.2018.4065 PMID: 32550322
15. Askarian M, Hosseini S, Kheirandish P. Incidence and Microorganisms Causing Nosocomial Infections in Ghotbeddin Burn Center of Shiraz, Iran, 2000-2001. Journal of Kerman University of Medical Sciences. 2003;10(4):65-70.
URL: https://jkmu.kmu.ac.ir/article_32882.html
16. Lari AR, Alaghehbandan R. Nosocomial infections in an Iranian burn care center. Burns. 2000;26(8):737-40.
DOI: 10.1016/s0305-4179(00)00048-6 PMID: 11024608
17. Oncul O, Ulkur E, Acar A, Turhan V, Yeniz E, Karacaer Z, et al. Prospective analysis of nosocomial infections in a burn care unit, Turkey. Indian J Med Res. 2009;130(6):758-64.
PMID: 20090139
18. Alatawi AD, Hetta HF, Ali MAS, Ramadan YN, Alaqyli AB, Alansari WK, et al. Diagnostic Innovations to Combat Antibiotic Resistance in Critical Care: Tools for Targeted Therapy and Stewardship. Diagnostics (Basel). 2025;15(17):2244.
DOI: 10.3390/diagnostics15172244 PMID: 40941733
Downloads
Published
Issue
Section
License
Copyright (c) 2025 The Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



